Can video texts and mailed kits boost colon cancer screening?
NCT ID NCT06542835
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a combination of tools—video messages, mailed stool test kits, and help with social needs—to encourage colorectal cancer screening among Latinx adults aged 45-64. About 6000 participants will receive these supports, and researchers will compare screening completion rates before and after the intervention. The goal is to find effective ways to reduce screening gaps and counter misinformation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that culturally tailored video messages and support services significantly increase colorectal cancer screening rates in underserved Latinx populations.
- What could go wrong
- This is a behavioral intervention trial, not testing a new drug or cure. Success depends on participants' engagement, and results may not apply to other groups or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AltaMed Health Services Corporation
RECRUITINGLos Angeles, California, 90040, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?